Quality Indicator Repository
Quality indicators are standardised, evidence-based measures used to monitor and evaluate the quality and safety of care. The ACAC developed a Quality Indicator Repository. For information on its development see this document.
Please navigate the Quality Indicator Repository to learn about the quality indicators we identified across care settings and their defining, data, and source attributes. You can also use the Quality Indicator Repository to download quality indicators of interest to you.
Proportion of patients whose ability to perform personal and instrumental activities of daily living was assessed as part of the diagnostic work-up.
Proportion of patients who are diagnosed with mild to moderate Alzheimer's disease and have acetylcholinesterase inhibitor (AChEI) prescribed/recommended.
The percentage of patients diagnosed with dementia whose care plan has been reviewed in the preceding 12 months.
Average daily dose per person per year of haloperidol, risperidone, zopiclone, hydroxyzine, oxazepam, or paracetamol.
Proportion of patients who have core blood tests undertaken as part of the diagnostic work-up.
Number of people with dementia (aged under 65 years) recorded on general practitioner (GP) practice registers, as a proportion of all people (aged under 65 years) registered at each GP practice.
The proportion of all dementia and Alzheimer deaths which took place in their usual place of residence. Usual residence is defined as: home, care homes (local authority and non-local authority) and religious establishments.
The percentage of patients diagnosed with dementia whose care plan has been reviewed in a face-to-face review in the preceding 12 months.
Directly age standardised rate of emergency inpatient hospital admissions for people with a mention of dementia or Alzheimer's in any of the diagnosis code positions (aged 65+) per 100,000 population.
Directly age standardised rate of mortality in persons (aged 65+) with a recorded mention of dementia or Alzheimer's per 100,000 population.
The rate of persons aged 65 and older with a recorded diagnosis of dementia per person estimated to have dementia given the characteristics of the population and the age and sex specific prevalence rates of the Cognitive Function and Ageing Study II, expressed as a percentage with 95 percent confidence intervals.
Proportion of patients whose first appointment are within 90 days of referral to the diagnostic service.
Proportion of patients for whom a multi-professional team has been involved.
Proportion of people with Alzheimer's disease who receive symptom-relieving antidementia drugs.
Investigation to diagnosis.
Number of people with dementia receiving a prescription for antipsychotic medication in the preceding 6 week period, as a percentage of all individuals with a formal diagnosis of dementia.
Medication reviews.
Proportion of patients who have multiple cognitive domains assessed as part of the diagnostic work-up.
Percentage of demented patients amongst number of referred.
Percentage of people estimated to be newly diagnosed with dementia who were referred for post-diagnostic support.
Percentage of people referred for post-diagnosis support who received a minimum of one year's support coordinated by a link worker, including the building of a person-centred support plan.
The percentage of older adults with diagnosed dementia who had a dispensed prescription for antipsychotics, benzodiazepines, nonbenzodiazepine hypnotics, tricyclic antidepressants or anticholinergic agent. This is reported as Potentially Harmful Drug-Disease Interactions in Older Adults, which assesses adults 65 years of age and older who have a specific disease or condition (chronic kidney disease, dementia, history of falls) and were dispensed a prescription for a medication that could exacerbate it.
The percentage of patients (aged 65+) with dementia as recorded on all open and active general practitioner (GP) practice disease registers. The recorded dementia prevalence provides an indication of the concentration, within a population, of the number of people aged 65 or older who have been diagnosed and who are now living with the condition. This indicator can be used to inform local service planning as to the scale of services required to provide treatment, care and support as needed, so those with dementia can live well with the condition.
Proportion of demented patients assessed with Instrumental Activities of Daily Living – Functional Assessment Questionnaire (IADL-FAQ) scale.
Proportion of demented patients assessed with Mini Mental State Examination (MMSE).